These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2504308)

  • 61. Optimal control of interferon-gamma and tumor necrosis factor-alpha by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction.
    Toungouz M; Denys C; de Groote D; Andrien M; Dupont E
    Transplantation; 1996 Feb; 61(3):497-502. PubMed ID: 8610367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma.
    Gottlieb DJ; Prentice HG; Mehta AB; Galazka AR; Heslop HE; Hoffbrand AV; Brenner MK
    Br J Haematol; 1990 Aug; 75(4):499-505. PubMed ID: 2119792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemia.
    Bergmann L; Heil G; Kolbe K; Lengfelder E; Puzicha E; Martin H; Lohmeyer J; Mitrou PS; Hoelzer D
    Leuk Lymphoma; 1995 Jan; 16(3-4):271-9. PubMed ID: 7719235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
    Levesque MC; Haynes BF
    J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    Nedwin GE; Svedersky LP; Bringman TS; Palladino MA; Goeddel DV
    J Immunol; 1985 Oct; 135(4):2492-7. PubMed ID: 3928750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
    Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
    Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of various cytokines on the induction of lymphokine-activated killer cells.
    Bergmann L; Weidmann E; Bungert B; Hechler P; Mitrou PS
    Nat Immun Cell Growth Regul; 1990; 9(4):265-73. PubMed ID: 2120581
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18.
    Wu TH; Pabin CN; Qin Z; Blankenstein T; Philip M; Dignam J; Schreiber K; Schreiber H
    J Immunol; 2004 Mar; 172(5):3243-51. PubMed ID: 14978132
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Defective expression of interferon-gamma, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and interleukin-6 in activated peripheral blood lymphocytes from glioma patients.
    Urbani F; Maleci A; La Sala A; Lande R; Ausiello CM
    J Interferon Cytokine Res; 1995 May; 15(5):421-9. PubMed ID: 7648444
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha.
    Danis VA; Kulesz AJ; Nelson DS; Brooks PM
    Clin Exp Immunol; 1990 Jun; 80(3):435-43. PubMed ID: 2115419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for involvement of TNF-alpha in the induction phase and IFN-beta in the effector phase of antiproliferative activity of splenic macrophages.
    Stout RD; Suttles J
    Cell Immunol; 1992 Feb; 139(2):363-74. PubMed ID: 1733508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
    Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
    Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy.
    Millar BC; Bell JB; Powles RL
    Br J Cancer; 1996 Jan; 73(2):236-40. PubMed ID: 8546912
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interferon-gamma+ and interleukin-2+ T cells in peripheral blood from multiple myeloma patients in relation to disease status and maintenance therapy with interferon-alpha2b (intron A).
    Millar BC; Millar JL; Powles RL; Catovsky D
    Br J Haematol; 1997 Jul; 98(1):119-25. PubMed ID: 9233574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor.
    Schiller JH; Witt PL; Storer B; Alberti D; Tombes MB; Arzoomanian R; Brown RR; Proctor RA; Voss SD; Spriggs DR
    Cancer; 1992 Jan; 69(2):562-71. PubMed ID: 1728387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.